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Abstract
Background: National cancer control plans (NCCPs) are important documents that guide strategic priorities in cancer 
care and plan for the appropriate allocation of resources based on the social, geographic and economic needs of a 
population. Despite the emphasis on health equity by the World Health Organization (WHO), few NCCPs have a focus 
on health equity. The Ontario Cancer Plan (OCP) IV, (2015 to 2019) is an example of an NCCP with clearly defined 
health equity goals and objectives.
Methods: This paper presents a directed-content analysis of the OCP IV health equity goals and objectives, in light of the 
synergies of oppression analytical framework. 
Results: The OCP IV confines equity to an issue of access-to-care. As a result, it calls for training, funding, and social 
support services to increase accessibility for high-risk population groups. However, equity has a broader definition. And 
as such, it also implies that systematic differences in health outcomes between social groups should be minimal. This is 
particularly significant given that socially disadvantaged cancer patients in Ontario have distinctly poorer cancer-related 
health outcomes. 
Conclusion: Health systems are seeking ways to reduce the health equity gap. However, to reduce health inequities 
which are socially-based will require a recognition of the living and working conditions of patients which influence risk, 
mortality and survival. NCCPs represent a way to politically advocate for the determinants of health which profoundly 
influence cancer risk, outcomes and mortality.
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Implications for policy makers
• National Cancer Control Plans (NCCPs) are important tools to plan for strategic priorities in cancer control and care based on the social, 
demographic and economic needs of a defined population.
• Both the World Health Organization (WHO) and the United Nations place an emphasis on health equity so that the health divide between 
population groups based on social location can be reduced.
• Only a third of global NCCPs currently have a health equity focus, and even fewer NCCPs set tangible goals and metrics to evaluate how health 
equity will be measured and achieved.
• For cancer, the unequal distribution of the social determinants of health (SDH) creates an unequal field for the delivery of cancer care. These 
conditions profoundly influence cancer risk, outcomes and mortality.
• NCCPs that include health equity as a goal will need to recognise the living and working conditions of cancer patients that influence their health 
outcomes and be ready to advocate for the social policies that affect the utilization of healthcare.
Implications for the public
Rising levels of income inequality are placing an increasing number of people in socially vulnerable circumstances. As a result, people who have 
access to fewer resources can have a hard time avoiding risk and maintaining good health. Indeed, when socially disadvantaged individuals they fall 
ill, it can be difficult for them to take time off work, and access medicines and care. Whilst many healthcare providers are aware of health inequities, 
the goals and objectives of health systems fail to encompass consideration of forces beyond the delivery of healthcare that can influence health 
outcomes. Health systems must be responsive to the living and working needs of the patients who they serve. And where needed health systems must 
raise a political voice to protect patients and promote their ability to seek and benefit from healthcare.
Key Messages 
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Key Terms
Health equity: The term health equity is used to define 
differences in health and access to healthcare amongst 
individuals who have different levels of underlying social 
advantage or disadvantage.1 
Social determinants of health (SDH): The SDH are the 
conditions in which we are born, grow, work and age. These 
conditions shape our daily lives, and impact our opportunities 
for health. They are themselves determined by the social and 
economic policies of the jurisdictions in which we live.2
Social location: The social location is also referred to as the 
social position. The rank order an individual occupies on a 
hierarchical ladder of power, privilege and prestige is called the 
social location. Many elements work in tandem, or intersect 
to influence the social location. These include material and 
social resources such as wealth and income; gender, age, 
religious affiliation, and mental or physical disability.3
Social inequity: Social inequity is a term which is used 
to describe the unequal distribution of power, privilege and 
prestige across a society. Inherently, individuals who occupy 
positions of social advantage by virtue of their personal 
wealth and credentials are more able to access resources and 
services4 thereby creating further differentiation between 
social groups.
Social structural inequality: Social structural inequality 
refers to the hierarchical ordering of people based on 
their position in society that is determined by their level 
of power, prestige and privilege. When social inequality 
becomes systematically entrenched in a society such that it 
is institutionalised into policies and procedures that continue 
to differentiate between social groups, it is called social 
structural inequality or social stratification.5
Cancer care continuum: The cancer care continuum 
is a conceptual pathway that represents the journey of an 
individual right through from cancer prevention, to screening, 
treatment, survivorship and end-of-life care.6
Introduction
Since the year 2000, there has been a steady increase in the 
number of national cancer control plans (NCCPs) across the 
globe.7 According to the World Health Organization (WHO), 
NCCPs are important tools to reduce incidence and mortality 
due to cancer, as well as improve the quality of life for cancer 
patients and their families.8 Ideally, systematic and evidence-
based goals are set by NCCPs based on the demographic, 
social and resource needs of the local population; with 
subsequent action on these goals leading to improvements in 
cancer prevention, early diagnosis, treatment and mortality.8 
As such, NCCPs are an important bridge between population 
needs and population health objectives and serve as a strategic 
roadmap for interventions and policy design.8 Whilst the 
WHO clearly highlights the importance of ensuring equity in 
the cancer-related health outcomes of a population,8 recent 
evaluations of 527 NCCPs across the globe have revealed 
that only a third of the plans have a focus on health equity.7 
Furthermore, it has been pointed out, that equity objectives 
in NCCPs typically fail to contextualise exactly how health 
equity will be achieved and/or measured.9
The cancer care system in Ontario, Canada is monitored 
and managed by an organization called Cancer Care Ontario 
(CCO). Every 4 years CCO releases a policy document called 
the Ontario Cancer Plan (OCP) to guide resource allocation 
and planning. The most recent OCP, OCP IV (2015 to 2019) 
has a clearly defined health equity goal with an ambition 
to “ensure health equity for all Ontarians across the cancer 
system.”6 In addition, the OCP IV distinctly articulates its 
strategic health equity objectives by committing to work with 
Indigenous populations, collect data, and inform locoregional 
policies and programs.6
Given that the OCP IV is amongst a handful of NCCPs 
that have a health equity priority, analysing the OCP IV from 
a health equity lens presents some novel opportunities. For 
starters, this plan can be considered an exemplar for how other 
health systems may choose to categorise their equity goals. 
It is therefore important to shed light on the health equity 
discourse in the OCP IV. Furthermore, since the document is 
a strategic roadmap, it is meaningful to understand the health 
equity implications of the planned objectives and the ability of 
proposed interventions to respond to the unequal allocation 
of the determinants of health which are socially based.
Background
CCO acts as a provincial advisor to the government and 
directly supervises approximately 1.8 billion dollars of 
cancer care through hospitals and service providers.10 CCO 
coordinates priorities and targets for cancer delivery between 
CCO, Regional Cancer Programs and the Ministry of Health 
and Long-Term Care, through a strategy document called 
the OCP. As an advisory document to the government, the 
OCP identifies unmet needs of cancer patients and their 
families, and brings to the limelight actionable methods to 
address them. As a result, the OCP-set, and government-
endorsed goals guide the allocation of funds, resources and 
health workers across the province to enhance the cancer care 
system. 
The OCP I was released in November 2004 and was a 
three-year roadmap that guided cancer care from 2005 to 
2008. Along with the second OCP, OCP II (2008 to 2011), 
these two strategic documents were focused on enhancing the 
capacity of the cancer system to keep up with the increasing 
incidence of cancer. They also laid the groundwork for quality 
monitoring and evaluation by synthesizing data collection 
into key performance indicators. The OCP III (2011 to 2015) 
was a 4-year plan committed to quality improvements across 
the cancer care continuum and a person-centered approach 
to care. The OCP IV (2015 to 2019) is the latest strategic plan 
from CCO that aims to further enhance the patient’s quality 
of life across the cancer care continuum in a manner that is 
both safe and equitable.6
Oversight for the work done by CCO is carried out by the 
Cancer Quality Council of Ontario, a partially independent 
body that evaluates the work carried out by the CCO and 
reports back to the CCO-Board and Ministry of Health and 
Long-Term Care. The Cancer Quality Council of Ontario 
also releases public reports thereby creating a degree of 
transparency into the functioning of Ontario’s cancer 
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system.11 Recent reports have rated CCO’s biomedical aspects 
of cancer care, such as safety, effectiveness and accessibility as 
“good”; whereas more holistic measures of patient care, such 
as responsiveness, equity and integration demonstrate room 
for improvement.11 These findings are in line with the Auditor 
General of Ontario’s report, which found inequities in cancer 
care across the province.12
In Ontario, innovative ways to tackle cancer are becoming 
increasingly important, and this is reflected in current policies 
and programs which strive to promote prevention, reduce risk, 
and make health services more accessible. What has not been 
well reflected in public policy or national strategy however, 
is the growing equity gap between those who survive cancer 
and those who do not. Almost twenty years ago, Mackillop et 
al,13 studied 360 000 cases of invasive cancer in Ontario and 
demonstrated how individuals from lower income groups 
were not only more likely to die of cancer, but that they were 
also more likely to die sooner than their richer counterparts. 
Interestingly, Booth et al,14 highlighted similar findings in a 
study conducted almost a decade later. Apparently, the more 
money one has, the greater their odds of overcoming cancer. 
And frighteningly, this is a finding that has persisted over 
time.
The SDH such as income and education are known to 
correlate with the stage of diagnosis,14 survival from,14 and 
quality of life15 with cancer.16 Recent austerity measures in 
Canada, with a retrenchment of the state from the provision of 
social services is increasing the pool of socially disadvantaged 
people.17 As a result, poverty levels, homelessness, food 
insecurity, and precarious working conditions are on the rise 
with a subsequent increase in income inequality.17 Whereas the 
correlation between income inequality and health inequality 
is well documented,18 this association is less apparent when 
it comes to the planning and delivery of health services for 
cancer care. 
Typically health systems have a focus on the acute 
management of illness, and for cancer systems this means 
that resources are frequently allocated to the delivery of good 
quality care for prevalent cancers. Populations that are harder 
to reach, or have poorer cancer-related health outcomes can 
be defined as priority populations,19 and for health systems 
an objective has been to enhance access to care via increased 
investment in material and human resources to deliver care. 
An inherent assumption in this process however, is that the 
accessibility of care will lead to its utilization, whereas evidence 
clearly points to the unequal utilization of health services 
amongst population groups based on their social location 
particularly for cancer care.20 Indeed, the structure and design 
of health services can impose a profound barrier to socially 
disadvantaged populations who may end up systematically 
excluded from programs, resulting in a worsening of health 
inequities.21
This paper explores the equity goal of the OCP IV: 2015-
2019 in light of the “synergies of oppression” framework 
constructed by McGibbon and McPherson,22 and highlights 
how a narrow conceptualisation of the term “equity” can be 
interpreted as top-down biomedical interventions which 
inherently favour the socially advantaged over those that are 
not. An implication of this is that social structural inequalities 
are almost completely ignored, and may have a counter 
productive effect of increasing the equity gap between rich 
and poor cancer patients. 
Methods
This study is a directed content analysis23 of the OCP IV 
(2015 to 2019) equity goal conducted using the synergies 
of oppression analytical framework22 and guided by the 
multilevel cancer systems model described by Taplin et al.24
McGibbon and McPherson22 use an intersectional lens to 
link feminist intersectionality theory with feminist political 
economy and complexity theory, to construct the “synergies 
of oppression” framework which illuminates how (i) social 
identities such as gender, race, class, disability, ethnicity, 
migrant status, culture and sexual orientation; (ii) SDH 
such as education, income, job, housing and food security; 
and (iii) social geography such as rural location, service 
accessibility, cultural segregation, environmental toxins, etc; 
can all cross paths and intersect to varying degrees resulting 
in lost opportunities for the health and wellbeing of women. 
Although the synergies of oppression framework has been 
used to illuminate gender specific inequalities,22 the concept 
is widely applicable to understand the role of social structural 
inequalities in mediating health inequities. In this paper, 
this analytical lens has been used as a tool to contextualize 
inequities in cancer care and outcomes. 
Taplin et al24 describe a multilevel ecological model of 
influencers across the cancer care continuum, based on the 
six dimensions of quality as described by the Institute of 
Medicine: safety, effectiveness, patient-centredness, equity, 
efficiency and timely care.25 Taplin et al24 define patient-
level success across the cancer care continuum as changes in 
patient risk, stage of diagnosis, quality of life, quality of death 
and financial burden; with these indicators subsequently 
feeding into long term markers of population-level success 
such as reduced cancer-related mortality and morbidity. The 
framework provided by Taplin et al24 was used to develop 
the methodological line of inquiry and to develop the study 
questions.
The study questions were: 
1. How does the OCP IV (hereafter termed OCP) 
conceptualise the term equity? 
2. When planning for risk reduction, does the OCP consider 
social inequalities as well as recognized biological factors?
3. What are the socioeconomic implications of cancer 
treatment, and how does this influence equitable 
outcomes of care?
4. How does the OCP propose to make end-of-life care 
choices equitable, and is the relationship between care 
choices and social location reflected in the OCP?
Results
Concepts of Equity in the Ontario Cancer Plan
After a call to action from the WHO commission to close the 
equity gap both between and within nations,2 health policies 
are increasingly building equity into their population plans. 
However, it is important to contextualize the scope and 
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breadth with which health policies use the term equity. How 
equity is defined and understood has direct implications into 
the translation of the policy words into actionable plans. For 
example, some policies specifically use the term equity in 
relation to geographic and financial accessibility of healthcare; 
whilst others use it to highlight differences in health status 
amongst groups.26 
When strategizing equity related goals, the OCP mentions 
the following policy objectives: 
“Develop locally relevant policies and programs in partnership 
with community service providers to improve access to services 
for specific populations and support healthcare providers with 
training, data and tools to deliver equitable services.”6 
“Advise governments in the development of provincial 
policies and programs to improve access to services for specific 
populations, including equitable access to specialized services.”6
“Ensure equitable access to palliative care for all Ontarians, 
including vulnerable populations.”6 
The OCP specifically links equity with accessibility. Hence 
the plan calls for: more centers, improved community outreach 
programs, enhanced provider cultural-linguistic competence, 
and identification of high-risk groups to facilitate access to 
care.
The OCP avoids planning for any health inequities that 
are beyond the scope of top-down biomedical interventions. 
Interestingly, the plan draws the link between equity and 
social identities only once in the entire plan. However, here 
too it is exclusively in the context of access: 
“Ontario’s population is diverse and geographically dispersed. 
Patient’s access to care and their health outcomes should not 
depend on demographic characteristics or where they live. Yet 
some Ontarians face significant, and often multiple, barriers in 
finding and accessing cancer services based on geography, race, 
culture, gender, age, sexual orientation, immigration status, 
and education.”6
The link between health equity, the SDH and barriers to 
care are also drawn only once in the OCP. Here too, it is in 
relation to accessibility of service: 
“We need to better understand the barriers that contribute 
to health disparities across the cancer care continuum, 
including barriers between health and community services to 
address SDH. We need to raise awareness among traditionally 
underserved populations about what services are available, how 
to access them and why it is important to do so.”6
Risk Reduction 
In the cancer care community, modifiable risk factors for 
cancer have been identified as smoking, obesity, lack of 
physical activity, unhealthy diet, alcohol consumption, and 
occupational and environmental exposures.27
As a result, the OCP quantifies the number of preventable 
cancers, and hence the importance of action to reduce risk: 
“In high-income countries similar to Canada, an estimated 
40% to 50% of cancers are associated with behavioural, 
occupational and environmental risk factors, and could be 
prevented. In light of our growing and aging population, 
initiatives that target modifiable risk factors take on added 
importance.”6
The OCP calls for reducing risk factors by identifying 
high risk individuals and community risk profiling to target 
interventions. 
“All Regional Cancer Centres developed programs to screen 
patients for smoking status and refer smokers to smoking 
cessation programs.”6
It is now well established that patterns of social disadvantage 
such as adverse working and living conditions are linked to the 
adoption of unhealthy lifestyle behaviours.28 Unfortunately, a 
failure to acknowledge this correlation in the OCP means that 
the plan falls short of fostering long term health equity in the 
population.
The OCP tasks individuals with the identification and 
management of their own cancer risk, and as such it suggests 
that logging onto an online portal can help reduce cancer risk: 
“MyCancerIQ launched in February 2015. This online cancer 
risk assessment tool will help to motivate Ontarians to reduce 
their risk of developing cancer and increase their participation 
in cancer screening.”6
It is important to understand however that this online 
tool may only be accessible, usable and beneficial to a select 
group of the population, most likely the socially advantaged. 
Biological risk can be shaped and structured by adverse 
working and living conditions which may not be amenable 
to individual choice. Examples of these include working 
night shifts,29 exposure to environmental toxins,29 and food 
insecurity30; all of which can contribute to a higher incidence 
of cancer. An online tool does not recognise social structural 
inequality which is a determinant of elevated cancer risk, and 
may inadvertently increase the health equity gaps based on 
participation by different population groups.
Cancer Related Expenses and Implications for Equitable 
Care 
In Canada, 70% of health services are funded through the 
state.31 Of the remaining 30 percent, approximately half are 
covered through employment-sponsored health plans, and the 
other half are paid directly out-of-pocket by cancer patients or 
their families.32 Studies demonstrate how low income, lack of 
health insurance and high levels of co-payment are associated 
with lack of adherence to oral anti-cancer drugs32 which is 
crucial for long-term disease-free survival.33 In recognition 
of this the OCP mentions two new drug reimbursement 
programs: 
“Cancer Care Ontario’s Provincial Drug Reimbursement 
Program launched 2 new programs to improve access to 
necessary cancer treatments across the province: The Evidence 
Building Program facilitated funding for treatment to 345 
patients while collecting real-world data on each medications 
clinical and cost-effectiveness; and the Case-by-Case Review 
Program helped approximately 50 cancer patients with 
immediately life-threatening circumstances receive treatments 
with drugs that would otherwise be unfunded.”6
Innovations in cancer therapy mean that intravenous 
chemotherapy is now increasingly available in an oral form.34 
As a result, therapy is increasingly being delivered at home 
rather than in the hospital. This phenomenon is referenced in 
the OCP in relation to patient safety: 
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“Patients and providers will be partners in designing how 
chemotherapy is delivered safely in the home.”6
What has not been mentioned in the OCP however, are 
the financial implications of changing the location of cancer 
therapy from in-hospital to at-home such that the responsibility 
to fund drugs is pushed from the state to the individual. The 
drug reimbursement plans mentioned in the OCP are not a 
response to the new ways in which cancer therapy is delivered 
or financed. Instead, the drug reimbursement plans serve 
select groups of patients, such as those on specific drugs and 
those in critical life-threatening situations. 
On average cancer patients participate approximately 36% 
less in the labour market, and as a result lose about 26% of 
their income.35 In this context, out of pocket expenses can 
become increasingly significant as personal income may 
continue to decline. Indeed, one in six cancer patients in 
Ontario feel that out of pocket costs are “significant” and 
“unmanageable.”32 Circumstances such as low levels of 
workplace flexibility are associated with increased job-loss, 
and a greater delay in return to work.36 In addition, caregivers 
too may lose approximately 25% of their income35 due to the 
increased burden of care. These financial constraints are not 
echoed in the wordings of the OCP. When cancer treatment 
is dependent on an individual’s ability to pay for it, CCO 
cannot consider equity in cancer care without addressing this 
fundamental issue.
End of Life Care
A goal of the OCP is to enhance the delivery of palliative care 
by bringing it closer to home. As such, the OCP commits to 
improve geographic access to palliative care. This objective 
however fails to contextualise the broader social circumstances 
of individuals that shape their end-of-life choices. 
“Patients will have discussions with their provider about 
advance care planning and will have the information they need 
to make informed decisions.”6
The main indicators of poor quality of end-of-life are: the 
number emergency department visits, and intensive care unit 
admissions within the last two weeks of life. Both of these 
have been consistently higher in cancer patients from the 
lowest income quintile in Ontario.11 Social identities such 
as gender, age, comorbidities intersect with the SDH such as 
income and education to predict end-of-life care.37 Indeed, 
studies demonstrate that up to 75 percent of cancer patients 
prefer to die at home.38 In Ontario however, only nine percent 
of cancer patients are able to do so, and this is primarily due 
to a lack of social support.11
Care at home requires caregivers. Studies have shown that 
caregivers who are younger, financially secure and physically 
fit are themselves optimally placed to provide end-of-life care 
at home.37 This is particularly apparent given that caregivers 
can lose up to 25% of their income as a result of caregiving 
responsibilities.35 However, to realise equitable end-of-life 
care, the OCP must take into account not only the psychosocial 
supports needed but also the financial leverages needed to 
enable this. The Quality Hospice Palliative Care Coalition 
of Ontario39 recommends: “expanded cash-for-care or direct 
payment funding schemes, and more flexible job benefits or 
protections for compassionate care leaves.” As direct advisor 
to the provincial government CCO is in a prime position to 
be making these specific policy recommendations but it fails 
to do so. 
Discussion
This paper explores inequities in cancer care in light of the 
“synergies of oppression” framework by McGibbon and 
McPherson.22 There is a growing body of evidence that links 
increased susceptibility to cancer, higher mortality, and poor 
quality of life with conditions of social disadvantage.40–42 
Indeed, social identities/ geographies, and SDH intersect 
across every stage of the cancer care continuum16 such that 
individuals who are socially advantaged are able to optimally 
utilize the healthcare system, negotiate better care, and 
enhance their opportunities for survival.20
According to Whitehead,26 policies must at the very least 
acknowledge the existence of social inequities in health. One 
of the key goals for the OCP is equity; however, the OCP 
contextualises equity almost exclusively as an access-to-care 
issue and as a result most actionable targets and supports 
driven out of the plan intervene to overcome cultural and 
financial barriers to access. The role of social identities and 
intersections with the SDH across the cancer care continuum 
are not contextualised within the OCP. As a result, it falls 
short of acknowledging and making accommodations to cater 
to these population needs. 
Innovations in cancer management imply that care is now 
increasingly delivered in the community or home. As such, 
individuals who lack social support are most likely to fall 
through the cracks during the delivery of care if their living 
and working conditions are not recognised. This is further 
compounded by rising levels of socioeconomic inequalities 
in Canada which increases the pool of socially disadvantaged 
individuals. 
As a policy advisor to the government, the OCP represents 
a lost opportunity to link top-down biomedical care, with 
bottom-up reforms in social policy and planning that 
will facilitate the utilization of care by cancer patients. 
Furthermore, the OCP can promote “glocalization,” also 
described as local action towards health equity to mitigate 
the effect of global economic forces,43 by advocating for the 
appropriate allocation of social resources which will enhance 
the living and working conditions of cancer patients. This 
will enable socially disadvantaged patients to interact with 
the health system and benefit from universally-available 
healthcare. 
One of the strengths of the OCP is the focus on Indigenous 
populations, and the Aboriginal (First Nations, Inuit, Métis 
or FNIM) Cancer strategy. A core emphasis of the FNIM plan 
is to build relationships and to nurture partnerships between 
Indigenous populations and CCO.6 It is well understood 
that this participatory approach will form the foundation of 
an equitable system where the cancer system can become 
accessible, acceptable and utilizable to the FNIM. This is 
reinforced by a data collection strategy to identify and measure 
equity gaps and create community cancer risk profiles.6
Despite the well-intentioned efforts of the FNIM health 
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equity strategy of the current OCP, few considerations 
remain: (i) to prevent “othering” it will be important to 
shift the language of the plan and objectives from one of 
cultural relevance (where Indigenous cultures are respected, 
acknowledged and used to train and build programs) to one 
which is grounded in cultural safety44 (where the sociopolitical 
lived realities of generations of Indigenous populations have 
lead to the cancer inequities which we see today); (ii) there is 
a danger of clustering all vulnerable populations together. As 
such, the intrinsic heterogeneity that exists within population 
groups as a result of their social location may not be amenable 
to a single intervention and may inadvertently widen the 
health equity gap45; and (iii) data should be used not only to 
build evidence for local and community-based action, but 
data should also be used to advocate to the government for 
upstream policy action that will improve the distribution of 
the SDH. 
As CCO prepares the next OCP, the OCP V, it must take 
into consideration its unique role as an interface between 
cancer patients and the government. Whilst a promise to 
deliver health equity to all Ontarians is noble, it must be 
backed by data, action and upstream political advocacy. To 
do this, CCO can assume governance roles for health equity 
that have been described by Labonte,46 such as : (i) The 
Watchdog: which monitors inequities in health and the SDH 
that underpin them; (ii) The Resource Broker: who ensures 
that adequate funding and resources are dedicated to tackling 
health inequities; (iii) The Community Developer: who works 
between health and community services to enhance the 
SDH; (iv) The Partnership Developer: who brings multiple 
stakeholders together to produce intersectoral action for 
health equity; and (v) the Advocate: who creates policy briefs 
to promote upstream action for health equity. 
Inherent in this paper is the SDH approach, and analysis 
of the OCP IV was done with a strong bias towards finding 
evidence to support this theory. According to Hsieh,23 this is 
one of the greatest limitations of conducting a directed content 
analysis. However, the OCP is a strategic policy document 
with a clearly defined health equity goal. Furthermore, given 
that the OCP is one of few NCCPs across the globe to have 
a focus on health equity, this study presents an important 
analysis which is of relevance to all stakeholders in cancer 
systems as they seek to reduce inequities in health. 
According to the 2030 Agenda for Sustainable Development 
it is a key healthcare imperative for nations to ensure that 
“no one is left behind” and that we are “reaching the furthest 
behind first.”47 As a result NCCPs are starting to build health 
equity goals and objectives into strategic priorities. As we 
move forward it will be necessary to collect more robust data 
on health equity. It will also be important to create indices 
that reflect the attainment of health equity goals, such as a 
percentage reduction in health outcomes between income 
groups, or improvement in healthcare utilization rates over 
time.9 However, it will be most significant to realise that 
health inequities are rooted in social inequities; and that 
the SDH play a profound role in cancer risk, outcomes and 
mortality. This will require NCCP’s to advocate for policies 
that influence the ability of patients to seek and benefit from 
care. Therefore NCCPs must not shy away from participating 
in political debates that subsequently influence social and 
health policy: As Navarro has succinctly put it, “you cannot 
speak of policies without touching on the politics.”48
Conclusion
Health systems have a mandate to deliver quality health 
services. Increasingly quality indicators include health 
equity, and as a result health system policy plans are focused 
on strategies to reduce health inequities across the patient 
population whom they serve. The traditional role of health 
systems has been limited to the delivery and implementation 
of health services equally across the population. However, 
now that health systems are beginning to focus on health 
equity, it is important to realise that health inequities arise 
as a result of socially-based inequities. Therefore, the ability 
of patients to successfully receive care is dependent on their 
living and working conditions. Health system plans and 
strategic roadmaps must build this realisation into their 
policy narrative.
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